Finance

Lists
301075:SHE
Tibet Duo Rui Pharmaceutical Co Ltd
CNÂ¥63.17
-1.33%
(-0.85) 1D
Sep 30, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301075...
Open
CNÂ¥64.10
High
CNÂ¥64.76
Low
CNÂ¥63.00
Mkt. cap
5.05B
Avg. vol.
1.22M
Volume
609.20K
52-wk high
CNÂ¥98.29
52-wk low
CNÂ¥40.91
EPS
-CNÂ¥0.62
Shares outstanding
80.00M
No. of employees
461
Open
CNÂ¥64.10
High
CNÂ¥64.76
Low
CNÂ¥63.00
Mkt. cap
5.05B
Avg. vol.
1.22M
Volume
609.20K
52-wk high
CNÂ¥98.29
52-wk low
CNÂ¥40.91
EPS
-CNÂ¥0.62
Shares outstanding
80.00M
No. of employees
461
News stories
From web sources and news partners
TradingView
TradingView
·
52 minutes ago
US Stocks Reverse Gains
شبكة تواصل الإخبارية
شبكة تواصل الإخبارية
·
2 hours ago
S&P 500 (US500) multi-dimensional structural breakdown | FXStreet
About Tibet Duo Rui Pharmaceutical Co Ltd
CEO-
Employees461
Founded2005
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
30.43M
17.18M
32.43M
63.22M
Cost of goods sold
32.04M
16.74M
29.99M
55.51M
Cost of revenue
32.04M
16.74M
29.99M
55.51M
Research and development expenses
20.93M
-8.19M
4.94M
8.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.76M
22.19M
15.08M
15.52M
Operating expense
47.89M
12.94M
17.03M
25.10M
Total operating expenses
79.93M
29.68M
47.01M
80.61M
Operating income
-49.50M
-12.51M
-14.58M
-17.38M
Other non operating income
-869.13K
-2.55M
-34.06K
-195.80K
EBT including unusual items
-52.43M
-20.21M
-18.95M
25.20M
EBT excluding unusual items
-54.28M
-19.39M
-17.93M
19.35M
Income tax expense
413.36K
-503.13K
62.27K
2.94M
Effective tax rate
-0.79%
2.49%
-0.33%
11.69%
Other operating expenses
1.76M
88.27K
-1.24M
2.31M
Net income
-37.22M
-22.44M
-13.97M
25.50M
Net profit margin
-122.35%
-130.64%
-43.07%
40.33%
Earnings per share
-
-
-
-
Interest and investment income
-
455.41K
18.98K
40.22M
Interest expense
-3.91M
-4.79M
-3.34M
-3.27M
Net interest expenses
-3.91M
-4.33M
-3.32M
36.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.82M
-296.34K
-2.37M
-4.81M
Gain or loss from assets sale
-9.56K
105.45K
-
-242.76K
AI content may include mistakes. Learn more
Google apps